#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia France Germany Hungary Ireland +6

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal Romania Spain

  • Study on Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to Current Treatment

    Not recruiting

    1 1
    Investigated drugs:
    Italy Spain

  • Study on the Effects of ATL1102 for Nonambulatory Patients with Duchenne Muscular Dystrophy

    Not recruiting

    1
    Investigated diseases:
    Investigated drugs:
    Bulgaria

  • Access to Mepolizumab for Patients with Hypereosinophilic Syndrome

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study of Visugromab and Nivolumab for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Refuse Cisplatin Chemotherapy

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +10